miR-3613-3p was shown to inhibit the growth of TNBC cell lines by targeting SMAD Family Member 2 (SMAD2) and Enhancer of Zeste Homolog 2 (EZH2), two important genes that implicate cell proliferation and cancer growth. Here, SMAD2 is linked to cancer.